BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31960419)

  • 1. Serum soluble VSIG4 as a surrogate marker for the diagnosis of lymphoma-associated hemophagocytic lymphohistiocytosis.
    Yuan S; Wang Y; Luo H; Jiang Z; Qiao B; Jiang Y; Hu Y; Cheng Y; Chen X; Gong W; Huang Y; Zhao W; Luo D; Liu B; Su H; Zhou J; Song S
    Br J Haematol; 2020 Apr; 189(1):72-83. PubMed ID: 31960419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome.
    Tsuji T; Hirano T; Yamasaki H; Tsuji M; Tsuda H
    Ann Hematol; 2014 May; 93(5):821-6. PubMed ID: 24705932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High concentration of miR-133 is a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndrome.
    Li W; Zhong Y; Shuang Y; Huang H; Huang Y; Yu L; Huang X
    Cancer Biomark; 2017 Aug; 20(2):159-164. PubMed ID: 28869447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum adenosine deaminase levels in secondary hemophagocytic lymphohistiocytosis.
    Chen W; Zhang S; Zhang W; Yang X; Xu J; Qiu H; Zhang X; Li J
    Int J Lab Hematol; 2015 Aug; 37(4):544-50. PubMed ID: 25764155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of soluble CD163 and soluble CD25 in diagnosis and treatment of children with hemophagocytic lymphohistiocytosis].
    Wang Y; Liu D; Zhu G; Yin C; Sheng G; Zhao X
    Zhonghua Er Ke Za Zhi; 2015 Nov; 53(11):824-9. PubMed ID: 26758320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble interleukin-2 receptor (sIL-2r) level is a limited test for the diagnosis of adult secondary hemophagocytic lymphohistiocytosis.
    Naymagon L; Tremblay D; Troy K; Mascarenhas J
    Eur J Haematol; 2020 Sep; 105(3):255-261. PubMed ID: 32353917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of HLH-2004 criteria in distinguishing malignancy-associated hemophagocytic lymphohistiocytosis.
    Gurunathan A; Boucher AA; Mark M; Prus KM; O'Brien MM; Breese EH; Mizukawa BE; Absalon MJ; Nelson AS; Jordan MB; Grimley MS; Lorsbach RB; Rotz SJ; Mathanda R; Kumar AR
    Pediatr Blood Cancer; 2018 Dec; 65(12):e27400. PubMed ID: 30272386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DEP regimen is superior to the HLH-1994 regimen as first-line therapy for lymphoma-associated haemophagocytic lymphohistiocytosis.
    Meng G; Wang Y; Wang J; Wang Z
    Leuk Lymphoma; 2021 Apr; 62(4):854-860. PubMed ID: 33225788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis.
    Zoref-Lorenz A; Murakami J; Hofstetter L; Iyer S; Alotaibi AS; Mohamed SF; Miller PG; Guber E; Weinstein S; Yacobovich J; Nikiforow S; Ebert BL; Lane A; Pasvolsky O; Raanani P; Nagler A; Berliner N; Daver N; Ellis M; Jordan MB
    Blood; 2022 Feb; 139(7):1098-1110. PubMed ID: 34780598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis.
    Lehmberg K; McClain KL; Janka GE; Allen CE
    Pediatr Blood Cancer; 2014 Nov; 61(11):2101-3. PubMed ID: 24753034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis.
    Knauft J; Schenk T; Ernst T; Schnetzke U; Hochhaus A; La Rosée P; Birndt S
    Leukemia; 2024 Feb; 38(2):235-249. PubMed ID: 38238443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive analysis of adult patients with secondary hemophagocytic lymphohistiocytosis: a prospective cohort study.
    Yoon SE; Eun Y; Huh K; Chung CR; Yoo IY; Cho J; Cho D; Ko YH; Park S; Kim WS; Kim SJ
    Ann Hematol; 2020 Sep; 99(9):2095-2104. PubMed ID: 32440790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for Early Diagnosis of Hemophagocytic Lymphohistiocytosis in Critically Ill Patients.
    Debaugnies F; Mahadeb B; Nagant C; Meuleman N; De Bels D; Wolff F; Gottignies P; Salaroli A; Borde P; Voué M; Corazza F
    J Clin Immunol; 2021 Apr; 41(3):658-665. PubMed ID: 33417087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the optimal serum ferritin level to identify hemophagocytic lymphohistiocytosis in the critical care setting.
    Saeed H; Woods RR; Lester J; Herzig R; Gul Z; Monohan G
    Int J Hematol; 2015 Aug; 102(2):195-9. PubMed ID: 25997871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
    Wang J; Wang D; Zhang Q; Duan L; Tian T; Zhang X; Li J; Qiu H
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):859-71. PubMed ID: 26666755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High soluble interleukin-2 receptor values in Indian paediatric & adult controls - Need for population-specific threshold in the diagnosis of haemophagocytic lymphohistiocytosis.
    Dinand V; Sachdeva A; Sharma S; Prasad A; Pant D; Sachdev A; Ganguly NK
    Indian J Med Res; 2021 Jun; 154(6):843-848. PubMed ID: 35662089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic biomarkers for adult haemophagocytic lymphohistiocytosis in critically ill patients (HEMICU): a prospective observational study protocol.
    Lachmann G; Knaak C; von Haefen C; Paeschke N; Meisel C; Nyvlt P; Schuster FS; Piper SK; Kruppa J; Vorderwülbecke G; Balzer F; La Rosée P; Schenk T; Unterwalder N; Kölsch U; Lachmann N; Akyüz L; Brunkhorst FM; Volk HD; Keh D; Spies C
    BMJ Open; 2019 Oct; 9(10):e032695. PubMed ID: 31666276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and Clinical Significance of Soluble B7-H3 in Patient with Secondary Hemophagocytic Lymphohistiocytosis].
    Lyu X; Wang Y; Wang LL; Yin GL; Liu LL; Duan LM; Tian T; Xu J; Qiu HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):1006-1011. PubMed ID: 32552973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Factors and Outcomes in Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-center Experience.
    Apodaca E; Rodríguez-Rodríguez S; Tuna-Aguilar EJ; Demichelis-Gómez R
    Clin Lymphoma Myeloma Leuk; 2018 Oct; 18(10):e373-e380. PubMed ID: 30037588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Th1/Th2 cytokine profiles between primary and secondary haemophagocytic lymphohistiocytosis.
    Chen Y; Wang Z; Luo Z; Zhao N; Yang S; Tang Y
    Ital J Pediatr; 2016 May; 42(1):50. PubMed ID: 27209435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.